1.
Renkhold L, Pereira MP, Loser K, Metze D, Baeumer D, Melzer N, et al. Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study. Acta Derm Venereol [Internet]. 2024 Nov. 20 [cited 2026 Jul. 11];104:adv40737. Available from: https://medicaljournalssweden.se/actadv/article/view/40737